Dopamine D2 Receptor Regulation: Mechanisms and Pathway

Dopamine D2 receptors (D2Rs) are critical regulators of dopamine signaling in the brain, influencing neuronal activity, neurotransmitter

Dopamine D2 receptors (D2Rs) are critical regulators of dopamine signaling in the brain, influencing neuronal activity, neurotransmitter release, and synaptic plasticity. Their regulation involves complex intracellular signaling cascades, receptor isoforms, and interactions with other proteins and ions that shape both normal brain function and disease states (Vallar & Meldolesi, 1989). Understanding how these receptors are controlled provides important insights into the neurobiological basis of behavior and the development of neuropsychiatric conditions.

D2R activation inhibits adenylate cyclase, which reduces cyclic adenosine monophosphate (cAMP) levels and blocks inositol triphosphate (IP3)–dependent calcium release from intracellular stores. This inhibition leads to increased potassium conductance that hyperpolarizes neurons, thereby suppressing neuronal excitability and reducing neurotransmitter release (Vallar & Meldolesi, 1989; Higley & Sabatini, 2010). D2Rs also regulate dopamine transporter (DAT) function through extracellular signal‑regulated kinase 1 and 2 (ERK1/2)–dependent pathways, which increase DAT surface expression and enhance dopamine clearance from the synaptic cleft (Bolan et al., 2007; Lycas et al., 2022).

D2 autoreceptors, located on dopamine‑releasing neurons, provide essential negative feedback by controlling dopamine synthesis, release, and uptake. This self‑regulation allows the brain to fine‑tune dopaminergic signaling and maintain homeostasis within neural circuits (Ford, 2014). Alterations in autoreceptor function are linked to disorders such as Parkinson’s disease, schizophrenia, and substance use disorders, which all involve dysregulated dopamine transmission (Ford, 2014; Chen et al., 2020). D2 heteroreceptors, found on non‑dopaminergic neurons, also influence dopamine levels by modulating neuronal excitability in regions such as the striatum and nucleus accumbens, producing region‑specific effects on behavior and reward processing (Anzalone et al., 2012).

D2Rs exist as two main isoforms: D2 short (D2S) and D2 long (D2L). The D2S isoform primarily mediates presynaptic regulation of dopamine synthesis and release, while D2L participates more in postsynaptic signaling and motor control (Lindgren et al., 2003). Both isoforms can compensate for each other under baseline conditions, but they perform distinct roles when dopaminergic activity is challenged, such as during pharmacological stimulation or disease states (Radl et al., 2017). These functional differences help explain how subtle genetic or biochemical disruptions in receptor balance can lead to altered movement, cognition, or motivation.

The affinity and conformation of D2Rs are regulated by ionic and molecular factors, including sodium levels and pH, which affect ligand binding and receptor activity (Neve, 1991). D2Rs also interact with various proteins and receptors that influence their function. For instance, they associate with the G‑protein‑coupled receptor–associated sorting protein (GASP), which directs receptor degradation and turnover, ensuring appropriate receptor availability at the cell surface (Bartlett et al., 2005). Additionally, D2Rs form functional heteromers with adenosine A2A receptors, creating complexes that competitively modulate calcium influx and N‑methyl‑D‑aspartate (NMDA) receptor signaling, particularly in striatal neurons (Azdad et al., 2009; Higley & Sabatini, 2010). These receptor interactions add another layer of regulation that coordinates dopaminergic activity with other neurotransmitter systems.

Altogether, dopamine D2 receptor regulation involves intricate intracellular signaling, isoform‑specific mechanisms, and dynamic interactions with ions and other proteins. These processes enable fine control of dopamine neurotransmission, which in turn influences motor activity, reward processing, learning, and cognition. Disruptions to D2R regulation are implicated in numerous neurological and psychiatric conditions, highlighting the receptor’s importance as both a fundamental biological regulator and a therapeutic target (Ford, 2014; Chen et al., 2020). A deeper understanding of these pathways may guide the development of more precise interventions for disorders characterized by dopamine imbalance.

References

Anzalone, A., Lizardi‑Ortiz, J., Ramos, M., De Mei, C., Hopf, F., Iaccarino, C., Halbout, B., Jacobsen, J., Kinoshita, C., Welter, M., Caron, M., Bonci, A., Sulzer, D., & Borrelli, E. (2012). Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors. The Journal of Neuroscience, 32(27), 9023–9034. https://doi.org/10.1523/jneurosci.0918‑12.2012

Azdad, K., Gall, D., Woods, A., Ledent, C., Ferré, S., & Schiffmann, S. (2009). Dopamine D2 and adenosine A2A receptors regulate NMDA‑mediated excitation in accumbens neurons through A2A–D2 receptor heteromerization. Neuropsychopharmacology, 34(4), 972–986. https://doi.org/10.1038/npp.2008.144

Bartlett, S., Enquist, J., Hopf, F., Lee, J., Gladher, F., Kharazia, V., Waldhoer, M., Mailliard, W., Armstrong, R., Bonci, A., & Whistler, J. (2005). Dopamine responsiveness is regulated by targeted sorting of D2 receptors. Proceedings of the National Academy of Sciences of the United States of America, 102(32), 11521–11526. https://doi.org/10.1073/pnas.0502418102

Bolan, E., Kivell, B., Jaligam, V., Oz, M., Jayanthi, L., Han, Y., Sen, N., Urizar, E., Gomes, I., Devi, L., Ramamoorthy, S., Javitch, J., Zapata, A., & Shippenberg, T. (2007). D2 receptors regulate dopamine transporter function via an extracellular signal‑regulated kinases 1 and 2‑dependent and phosphoinositide 3 kinase‑independent mechanism. Molecular Pharmacology, 71(5), 1222–1232. https://doi.org/10.1124/mol.106.027763

Chen, R., Ferris, M., & Wang, S. (2020). Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder. Pharmacology & Therapeutics, 107, 583. https://doi.org/10.1016/j.pharmthera.2020.107583

Ford, C. (2014). The role of D2‑autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience, 282, 13–22. https://doi.org/10.1016/j.neuroscience.2014.01.025

Higley, M., & Sabatini, B. (2010). Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors. Nature Neuroscience, 13(8), 958–966. https://doi.org/10.1038/nn.2592

Lindgren, N., Usiello, A., Goiny, M., Haycock, J., Erbs, E., Greengard, P., Hökfelt, T., Borrelli, E., & Fisone, G. (2003). Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proceedings of the National Academy of Sciences of the United States of America, 100(8), 4305–4309. https://doi.org/10.1073/pnas.0730708100

Lycas, M., Ejdrup, A., Sørensen, A., Haahr, N., Jørgensen, S., Guthrie, D., Støier, J., Werner, C., Newman, A., Sauer, M., Herborg, F., & Gether, U. (2022). Nanoscopic dopamine transporter distribution and conformation are inversely regulated by excitatory drive and D2 autoreceptor activity. Cell Reports, 40(4), 111431. https://doi.org/10.1016/j.celrep.2022.111431

Neve, K. (1991). Regulation of dopamine D2 receptors by sodium and pH. Molecular Pharmacology, 39(4), 570–578. https://doi.org/10.1016/s0026‑895x(25)11023‑7

Radl, D., Chiacchiaretta, M., Lewis, R., Brami‑Cherrier, K., Arcuri, L., & Borrelli, E. (2017). Differential regulation of striatal motor behavior and related cellular responses by dopamine D2L and D2S isoforms. Proceedings of the National Academy of Sciences, 115(1), 198–203. https://doi.org/10.1073/pnas.1717194115

Vallar, L., & Meldolesi, J. (1989). Mechanisms of signal transduction at the dopamine D2 receptor. Trends in Pharmacological Sciences, 10(2), 74–77. https://doi.org/10.1016/0165‑6147(89)90082‑5